These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
280 related articles for article (PubMed ID: 10454453)
21. T-type and L-type calcium channel blockers exert opposite effects on renin secretion and renin gene expression in conscious rats. Wagner C; Krämer BK; Hinder M; Kieninger M; Kurtz A Br J Pharmacol; 1998 Jun; 124(3):579-85. PubMed ID: 9647484 [TBL] [Abstract][Full Text] [Related]
22. Effects of amlodipine on glomerular filtration, growth, and injury in experimental hypertension. Dworkin LD; Tolbert E; Recht PA; Hersch JC; Feiner H; Levin RI Hypertension; 1996 Feb; 27(2):245-50. PubMed ID: 8567047 [TBL] [Abstract][Full Text] [Related]
23. Sildenafil augments the beneficial hemodynamic and histopathological effects of amlodipine in nitric oxide-deficient hypertensive rats: role of nitric oxide-cyclic GMP pathway. Aboutabl ME; Raafat M; Maklad YA; Kenawy SA; El Din AG Pharmacol Res; 2008 Jun; 57(6):456-63. PubMed ID: 18572415 [TBL] [Abstract][Full Text] [Related]
25. Imidapril improves L-NAME-exacerbated nephrosclerosis with TGF-beta 1 inhibition in spontaneously hypertensive rats. Ono H; Saitoh M; Ono Y; Ishimitu T; Matsuoka H J Hypertens; 2004 Jul; 22(7):1389-95. PubMed ID: 15201556 [TBL] [Abstract][Full Text] [Related]
26. Apoptosis and glomerular injury after prolonged nitric oxide synthase inhibition in spontaneously hypertensive rats. Ono H; Ono Y; Takanohashi A; Matsuoka H; Frohlich ED Hypertension; 2001 Dec; 38(6):1300-6. PubMed ID: 11751707 [TBL] [Abstract][Full Text] [Related]
27. Calcium channel blockades exhibit anti-inflammatory and antioxidative effects by augmentation of endothelial nitric oxide synthase and the inhibition of angiotensin converting enzyme in the N(G)-nitro-L-arginine methyl ester-induced hypertensive rat aorta: vasoprotective effects beyond the blood pressure-lowering effects of amlodipine and manidipine. Toba H; Nakagawa Y; Miki S; Shimizu T; Yoshimura A; Inoue R; Asayama J; Kobara M; Nakata T Hypertens Res; 2005 Aug; 28(8):689-700. PubMed ID: 16392774 [TBL] [Abstract][Full Text] [Related]
28. Comparative efficacy and tolerability of two long-acting calcium antagonists, mibefradil and amlodipine, in essential hypertension. Mibefradil Hypertension Study Group. Karch FE; Pordy R; Benz JR; Carr A; Lunde NM; Marbury T; Tarro JN Clin Ther; 1997; 19(6):1368-78. PubMed ID: 9444446 [TBL] [Abstract][Full Text] [Related]
29. Aldosterone antagonism ameliorates proteinuria and nephrosclerosis independent of glomerular dynamics in L-NAME/SHR model. Zhou X; Ono H; Ono Y; Frohlich ED Am J Nephrol; 2004; 24(2):242-9. PubMed ID: 15031627 [TBL] [Abstract][Full Text] [Related]
30. Mibefradil. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the management of hypertension and angina pectoris. Brogden RN; Markham A Drugs; 1997 Nov; 54(5):774-93. PubMed ID: 9360062 [TBL] [Abstract][Full Text] [Related]
31. Long-term calcium antagonist treatment of human hypertension with mibefradil or amlodipine increases sympathetic nerve activity. Lindqvist M; Kahan T; Melcher A; Ekholm M; Hjemdahl P J Hypertens; 2007 Jan; 25(1):169-75. PubMed ID: 17143189 [TBL] [Abstract][Full Text] [Related]
32. Comparative effects of mibefradil and other calcium antagonists on resistance arteries of different end organs. van der Lee R; Pfaffendorf M; van Zwieten PA Fundam Clin Pharmacol; 1999; 13(2):198-203. PubMed ID: 10226764 [TBL] [Abstract][Full Text] [Related]
33. Effect of nitric oxide synthase inhibitor N(omega) nitro-L-arginine methyl ester on relaxant responses to calcium channel antagonists in isolated aortic rings from Dahl normotensive and hypertensive rats. Duggan JA; Tabrizchi R J Cardiovasc Pharmacol; 2002 Mar; 39(3):354-62. PubMed ID: 11862114 [TBL] [Abstract][Full Text] [Related]
34. Mineralocorticoid receptor blockade and calcium channel blockade have different renoprotective effects on glomerular and interstitial injury in rats. Du J; Fan YY; Hitomi H; Kiyomoto H; Kimura S; Kong CZ; Noma T; Kohno M; Nishiyama A; Nakano D Am J Physiol Renal Physiol; 2009 Sep; 297(3):F802-8. PubMed ID: 19535572 [TBL] [Abstract][Full Text] [Related]
36. Divergent effects of calcium channel and angiotensin converting enzyme blockade on glomerulotubular function in cyclosporine-treated renal allograft recipients. Sennesael JJ; Lamote JG; Violet I; Tasse S; Verbeelen DL Am J Kidney Dis; 1996 May; 27(5):701-8. PubMed ID: 8629631 [TBL] [Abstract][Full Text] [Related]
37. Effect of calcium channel blockade or angiotensin-converting enzyme inhibition on structure of coronary, renal, and other small arteries in spontaneously hypertensive rats. Li JS; Schiffrin EL J Cardiovasc Pharmacol; 1996 Jul; 28(1):68-74. PubMed ID: 8797138 [TBL] [Abstract][Full Text] [Related]
38. Human vascular to cardiac tissue selectivity of L- and T-type calcium channel antagonists. Sarsero D; Fujiwara T; Molenaar P; Angus JA Br J Pharmacol; 1998 Sep; 125(1):109-19. PubMed ID: 9776350 [TBL] [Abstract][Full Text] [Related]
39. Endothelin antagonism in end-organ damage of spontaneously hypertensive rats. Comparison with angiotensin-converting enzyme inhibition and calcium antagonism. Karam H; Heudes D; Bruneval P; Gonzales MF; Löffler BM; Clozel M; Clozel JP Hypertension; 1996 Sep; 28(3):379-85. PubMed ID: 8794820 [TBL] [Abstract][Full Text] [Related]
40. Antihypertensive agents prevent nephrosclerosis and left ventricular hypertrophy induced in rats by prolonged inhibition of nitric oxide synthesis. Akuzawa N; Nakamura T; Kurashina T; Saito Y; Hoshino J; Sakamoto H; Sumino H; Ono Z; Nagai R Am J Hypertens; 1998 Jun; 11(6 Pt 1):697-707. PubMed ID: 9657629 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]